Work for Allena Pharmaceuticals, Inc.?

Claim Your Profile

Allena Pharmaceuticals, Inc. Logo Image

Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. Banner Image

About Allena Pharmaceuticals, Inc.

11-50 Employees
Based in Newton, Massachusetts

Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.

Ticker:
ALNA
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol